Gynogen HP 75 IU Injection (Menotropin) for Female Infertility
Pay in 3 Installments of
Rs.
575
JazzCash
easypaisa
NayaPay
Bank transfer
Cash on Delivery
Description
Gynogen HP 75 IU — Menotropin Injection for Ovarian Stimulation & Female Infertility
Gynogen HP 75 IU Injection contains Menotropin (human Menopausal Gonadotropin, hMG) — a purified preparation of FSH (Follicle-Stimulating Hormone) and LH (Luteinising Hormone) for controlled ovarian stimulation in women undergoing fertility treatment.
The 75 IU dose is the lower-strength formulation (compared to Gynogen HP 150 IU), designed for milder stimulation protocols, women sensitive to gonadotropins (e.g., PCOS patients with low-dose step-up protocols), or as part of individualised ART regimens under strict ultrasound and hormonal monitoring. Menotropin stimulates follicular recruitment and growth, increasing mature oocytes available for natural conception, IUI, or IVF. Administered subcutaneously or intramuscularly under reproductive endocrinologist supervision. Regular transvaginal ultrasound and serum oestradiol monitoring is essential to track response and prevent Ovarian Hyperstimulation Syndrome (OHSS). Prescription Required.
How to Buy Gynogen HP 75 IU at Derma.pk
Find Gynogen HP 75 IU in Injections or Sexual Health on Derma.pk. Send your prescription via Email: sales@derma.pk or WhatsApp: +92-320-5999650. Nationwide delivery available.
Usage & Benefits
- Follicular stimulation for fertility: Menotropin's FSH component stimulates ovarian follicle recruitment and maturation, and LH supports follicular development and luteinisation.
- Lower-dose precision: The 75 IU dose allows more granular dose titration — suitable for step-up protocols in normogonadotrophic women and PCOS patients sensitive to gonadotropins.
- Reduced OHSS risk vs 150 IU: Starting at 75 IU minimises ovarian hyperstimulation risk in PCOS and other high-responder patient groups.
- Supports IUI and IVF: Used in both intrauterine insemination (IUI) and in-vitro fertilisation (IVF) / ICSI stimulation protocols under specialist direction.
- Authentic gonadotropin: Purified hMG from post-menopausal urine provides both FSH and LH activity required for complete follicular development.
How To Use
1. Use only as directed by your reproductive endocrinologist or fertility specialist. The standard protocol involves daily injections starting from cycle day 2 or 3. The 75 IU dose may be titrated upward (step-up protocol) based on ovarian response assessed by transvaginal ultrasound and serum oestradiol levels every 2–3 days. Do not self-administer without specialist training. An hCG trigger injection is given to induce final oocyte maturation when leading follicles reach the target size. Ovarian Hyperstimulation Syndrome (OHSS) monitoring is essential throughout the cycle. Prescription Required.
FAQs
How is Gynogen HP 75 IU different from 150 IU?
The 75 IU dose provides milder follicular stimulation, suitable for patients sensitive to gonadotropins, PCOS patients on step-up protocols, or IUI cycles. The 150 IU dose is used for more aggressive stimulation in IVF or lower-responder patients.
What is OHSS and how is it monitored?
Ovarian Hyperstimulation Syndrome (OHSS) is an over-response to gonadotropin stimulation. Starting at 75 IU reduces OHSS risk. Monitoring involves regular ultrasound to count follicles and measure oestradiol — if too many follicles develop, the cycle may be cancelled or converted to freeze-all to prevent severe OHSS.
How long does a menotropin injection cycle last?
Typically 8–14 days of daily injections, with monitoring every 2–3 days, followed by an hCG trigger injection when follicles reach the target size (usually 17–18mm).
Is Gynogen HP 75 IU suitable for PCOS?
Yes — PCOS patients are particularly suited to the 75 IU low-dose step-up protocol to achieve mono-follicular development for IUI, minimising multi-foetal pregnancy and OHSS risk.
Can Gynogen HP be self-administered at home?
With proper training from your fertility clinic, subcutaneous injections can be self-administered. However, monitoring appointments (ultrasound and blood tests) must be attended as scheduled.
